Hoste A M, Sys S U
Department of Ophthalmology, University of Antwerp, Belgium.
Curr Eye Res. 1994 Jul;13(7):483-7. doi: 10.3109/02713689408999879.
We investigated the possible effects on retinal blood flow of betaxolol, a beta blocker which is used as antiglaucomatous medication. Ring segments of retinal microarteries were isolated from bovine eyes and mounted in an organ bath for measurement of contractile force. The effects of betaxolol were studied during K(+)-, stretch-, and serotonin-induced contractions, to enable comparison to the effects of the standard beta blocker propranolol and the Ca2+ channel blocker verapamil. Betaxolol relaxed K(+)-induced contractions in a dose-dependent manner. The drug relaxed the phasic part of the K(+)-induced contractions more than the tonic part. Betaxolol had no effect on stretch-induced contractions. The tonic part of the serotonin-induced contractions showed a trend to decrease in response to betaxolol. These highly specific effects of betaxolol resembled the effects of propranolol. Since betaxolol has significantly less membrane stabilizing activity than has propranolol, this activity is not responsible for the relaxant action of beta blockers on retinal microarteries. The action of both beta blockers resembled the action of the Ca2+ channel blocker verapamil.
我们研究了倍他洛尔(一种用作抗青光眼药物的β受体阻滞剂)对视网膜血流的可能影响。从牛眼中分离出视网膜微动脉的环段,并将其安装在器官浴槽中以测量收缩力。在钾离子、牵张和5-羟色胺诱导的收缩过程中研究了倍他洛尔的作用,以便与标准β受体阻滞剂普萘洛尔和钙通道阻滞剂维拉帕米的作用进行比较。倍他洛尔以剂量依赖的方式舒张钾离子诱导的收缩。该药物对钾离子诱导收缩的时相部分的舒张作用大于张力部分。倍他洛尔对牵张诱导的收缩无作用。5-羟色胺诱导收缩的张力部分对倍他洛尔有下降趋势。倍他洛尔的这些高度特异性作用类似于普萘洛尔的作用。由于倍他洛尔的膜稳定活性明显低于普萘洛尔,因此该活性与β受体阻滞剂对视网膜微动脉的舒张作用无关。两种β受体阻滞剂的作用类似于钙通道阻滞剂维拉帕米的作用。